Gilder Gagnon Howe & Co’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $24M | Sell |
|
|||||
|
2025
Q2 | $20.1M | Buy |
|
|||||
|
2025
Q1 | $4.23M | Buy |
|
|||||
|
2024
Q4 | $1.35M | Sell |
|
|||||
|
2024
Q3 | $1.26M | Buy |
|
|||||
|
2024
Q2 | $1.12M | Sell |
|
|||||
|
2024
Q1 | $1.4M | Buy |
|
|||||
|
2023
Q4 | $1.62M | Sell |
|
|||||
|
2023
Q3 | $1.06M | Buy |
|
|||||
|
2023
Q2 | $612K | Buy |
|
|||||
|
2023
Q1 | $528K | Sell |
|
|||||
|
2022
Q4 | $248K | Sell |
|
|||||
|
2022
Q3 | $481K | Sell |
|
|||||
|
2022
Q2 | $443K | Sell |
|
|||||
|
2022
Q1 | $8.58M | Sell |
|
|||||
|
2021
Q4 | $14.1M | Buy |
|
|||||
|
2021
Q3 | $35.4M | Sell |
|
|||||
|
2021
Q2 | $46.2M | Sell |
|
|||||
|
2021
Q1 | $47.1M | Buy |
|